ACTRN12605000681651尚未招募3 期
ong Term Immunogenicity of the Japanese Encephalitis Vaccine IC51 (JE-PIV).
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- Intercell AG
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Healthy subjects. Written informed consent obtained prior to study entry.
排除标准
- •No exclusion criteria
研究者
相似试验
进行中（未招募）
不适用
ONG TERM IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS VACCINEIC51 (JE-PIV). AN UNCONTROLLED PHASE 3 FOLLOW-UP STUDY - IC51-303Japanese encephalitis. This study is a follow-up to the pivotal immunogenicity and safety studies IC51-301 and IC51-302.EUCTR2005-000253-29-DEIntercell AG3,300
进行中（未招募）
不适用
ONG TERM IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS VACCINEIC51 (JE-PIV). AN UNCONTROLLED PHASE 3 FOLLOW-UP STUDY - IC51-303EUCTR2005-000253-29-ATIntercell AG3,300
进行中（未招募）
1 期
ONG TERM IMMUNOGENICITY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (JE-PIV). AN UNCONTROLLED PHASE 3 FOLLOW-UP STUDY - IC51-303EUCTR2005-000253-29-GBIntercell AG4,333
进行中（未招募）
不适用
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic CountriesJapanese Encephalitis (JE)MedDRA version: 13.1Level: PTClassification code 10014596Term: Encephalitis Japanese BSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023120Term: Japanese B viral encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023123Term: Japanese encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023122Term: Japanese B virus encephalitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: LLTClassification code 10023119Term: Japanese B encephalitisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-015595-10-SEIntercell AG100
进行中（未招募）
不适用
IMMUNOGENICITY AND SAFETY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO®, JESPECT®) IN A PEDIATRIC POPULATION IN NON-ENDEMIC COUNTRIES. UNCONTROLLED, OPEN-LABEL PHASE 3 STUDYJapanese Encephalitis (JE)MedDRA version: 12.0Level: LLTClassification code 10014596Term: Encephalitis Japanese BMedDRA version: 12.0Level: LLTClassification code 10023119Term: Japanese B encephalitisMedDRA version: 12.0Level: LLTClassification code 10023120Term: Japanese B viral encephalitisMedDRA version: 12.0Level: LLTClassification code 10023122Term: Japanese B virus encephalitisMedDRA version: 12.0Level: LLTClassification code 10023123Term: Japanese encephalitisEUCTR2009-015595-10-DKIntercell AG100